M

Maat Pharma SA
PAR:MAAT

Watchlist Manager
Maat Pharma SA
PAR:MAAT
Watchlist
Price: 3.96 EUR -3.41% Market Closed
Market Cap: 63.9m EUR

Wall Street
Price Targets

MAAT Price Targets Summary
Maat Pharma SA

Wall Street analysts forecast MAAT stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for MAAT is 18.44 EUR with a low forecast of 16.67 EUR and a high forecast of 22.05 EUR.

Lowest
Price Target
16.67 EUR
321% Upside
Average
Price Target
18.44 EUR
366% Upside
Highest
Price Target
22.05 EUR
457% Upside
Maat Pharma SA Competitors:
Price Targets
MDGL
Madrigal Pharmaceuticals Inc
8% Upside
005690
Pharmicell Co Ltd
35% Upside
NTLA
Intellia Therapeutics Inc
123% Upside
000403
Pacific Shuanglin Bio pharmacy Co Ltd
25% Upside
GLPG
Galapagos NV
2% Upside
COYA
Coya Therapeutics Inc
209% Upside
RCUS
Arcus Biosciences Inc
140% Upside
KNSA
Kiniksa Pharmaceuticals Ltd
29% Upside

Revenue
Forecast

Revenue Estimate
Maat Pharma SA

The compound annual growth rate of Maat Pharma SA's revenue for the next 3 years is 121%.

N/A
Past Growth
121%
Estimated Growth
Estimates Accuracy
-25%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Maat Pharma SA

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Net Income
Forecast

Net Income Estimate
Maat Pharma SA

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-35%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is MAAT's stock price target?
Price Target
18.44 EUR

According to Wall Street analysts, the average 1-year price target for MAAT is 18.44 EUR with a low forecast of 16.67 EUR and a high forecast of 22.05 EUR.

What is Maat Pharma SA's Revenue forecast?
Projected CAGR
121%

The compound annual growth rate of Maat Pharma SA's revenue for the next 3 years is 121%.

Back to Top